Kidney failure: Aims for the next 10 years and barriers to success

Giuseppe Remuzzi, Ariela Benigni, Fredric O. Finkelstein, Jean Pierre Grunfeld, Dominique Joly, Ivor Katz, Zhi Hong Liu, Toshio Miyata, Norberto Perico, Bernardo Rodriguez-Iturbe, Luca Antiga, Franz Schaefer, Arrigo Schieppati, Robert W. Schrier, Marcello Tonelli

Research output: Contribution to journalReview article

42 Citations (Scopus)

Abstract

Although in some parts of the world acute and chronic kidney diseases are preventable or treatable disorders, in many other regions these diseases are left without any care. The nephrology community needs to commit itself to reduction of this divide between high-income and low-income regions. Moreover, new and exciting developments in fields such as pharmacology, genetic, or bioengineering, can give a boost, in the next decade, to a new era of diagnosis and treatment of kidney diseases, which should be made available to more patients.

Original languageEnglish
Pages (from-to)353-362
Number of pages10
JournalThe Lancet
Volume382
Issue number9889
DOIs
Publication statusPublished - 2013

ASJC Scopus subject areas

  • Medicine(all)

Fingerprint Dive into the research topics of 'Kidney failure: Aims for the next 10 years and barriers to success'. Together they form a unique fingerprint.

  • Cite this

    Remuzzi, G., Benigni, A., Finkelstein, F. O., Grunfeld, J. P., Joly, D., Katz, I., Liu, Z. H., Miyata, T., Perico, N., Rodriguez-Iturbe, B., Antiga, L., Schaefer, F., Schieppati, A., Schrier, R. W., & Tonelli, M. (2013). Kidney failure: Aims for the next 10 years and barriers to success. The Lancet, 382(9889), 353-362. https://doi.org/10.1016/S0140-6736(13)60438-9